This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Medproject Pharma-Entwicklungs-Und Vertriebsgesellschaft Mbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jürgen Senge: Innovator in Ophthalmic Gel Technology
Introduction
Jürgen Senge is a notable inventor based in Grünwald, Germany. He has made significant contributions to the field of ophthalmic solutions, particularly with his innovative patent for a drippable ophthalmic gel. His work has the potential to enhance the treatment of various eye conditions.
Latest Patents
Senge holds a patent for a product titled "Drippable Ophthalmic Bimatoprost Gel." This invention refers to a drippable ophthalmic gel that comprises bimatoprost in an amount of 0.003 to 0.03% by weight, along with polyacrylate, povidone (PVP), dextrane, polyethylene glycols (PEG), carboxymethyl cellulose (CMC), or poly(vinyl alcohol) (PVA) in varying amounts. The gel is designed to have an osmolality of 200 to 400 mosml/kg and a viscosity ranging from 200 to 2000 mPa·s, making it suitable for ophthalmic applications.
Career Highlights
Throughout his career, Jürgen Senge has worked with Medproject Pharma-Entwicklungs- und Vertriebsgesellschaft mbH, where he has contributed to the development of pharmaceutical products. His expertise in ophthalmic formulations has positioned him as a valuable asset in the industry.
Collaborations
Senge has collaborated with notable professionals in the field, including Heinz Polzer and Pierre-Paul Elena. These partnerships have furthered his research and development efforts in ophthalmic technologies.
Conclusion
Jürgen Senge's innovative work in ophthalmic gel technology exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in eye care solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile